Search

Your search keyword '"Vercelletto, Martine"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Vercelletto, Martine" Remove constraint Author: "Vercelletto, Martine"
171 results on '"Vercelletto, Martine"'

Search Results

1. Phenotype and imaging features associated with APP duplications

2. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

3. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

4. Frontotemporal dementia and its subtypes: a genome-wide association study

5. Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

6. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

9. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

10. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias

11. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning: Dementia Praecox Revisited

12. Semantic Memory Test

13. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

14. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls

15. Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia

17. General practice-based intervention for suspecting and detecting dementia in France A cluster randomized controlled trial

18. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study

19. Progranulin Null Mutations in Both Sporadic and Familial Frontotemporal Dementia

20. Mutations Other Than Null Mutations Producing a Pathogenic Loss of Progranulin in Frontotemporal Dementia

21. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia

22. Phenotype associated with APP duplication in five families

23. Added value of 18 F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

24. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

25. Primary progressive aphasias associated with C9orf72 expansions: Another side of the story

26. Diabetes Mellitus and Cognition

27. Primary Progressive Aphasia Associated With GRNMutations

28. Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates

29. Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates

30. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls

31. Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates

33. Apport du test de mémoire sémantique 42 items (TMS-42) en consultation mémoire

34. Assessment of semantic memory with the SMT-42

36. P1-394: Prevalence and Characteristics of Patients with Alzheimer’s Disease Eligible for a Disease Modifying Drug (Panacea)

38. DAPHNE: A New Tool for the Assessment of the Behavioral Variant of Frontotemporal Dementia

39. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts

40. The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study

41. A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease

42. Identification et validation d’une signature transcriptomique sanguine d’aide au diagnostic de la maladie d’Alzheimer (ACLARUSDX™)

43. A Phenotype of Atypical Apraxia of Speech in a Family Carrying SQSTM1 Mutation

44. P4‐085: MEMENTO: A NATIONAL COHORT ON DETERMINANTS AND BIOMARKERS OF ALZHEIMER'S DISEASE AND ASSOCIATED DISORDERS

45. P1-249: ASSOCIATION BETWEEN MULTIPLE NEUROIMAGING MARKERS AND COGNITIVE PROFILES IN THE MEMENTO COHORT

47. DCTN1Mutation Analysis in Families With Progressive Supranuclear Palsy–Like Phenotypes

50. Les traitements symptomatiques dans la maladie d'Alzheimer en 2016: à partir des Centres mémoire ressources recherche (CMRR) en France.

Catalog

Books, media, physical & digital resources